Hernia pulmonar espontánea: reporte de caso

Introducción: La hernia pulmonar espontánea es una entidad muy poco frecuente. Corresponde a la protrusión del parénquima pulmonar y pleura a través de un defecto de la pared torácica. Está causado por el aumento de la presión intratorácica asociado a la debilidad de la pared. Caso Clínico: Presentamos el caso de un paciente asmático con diagnóstico de hernia pulmonar espontánea de la pared torácica y su resolución quirúrgica. El tratamiento varía según el caso y no existe consenso respecto al manejo conservador vs quirúrgico ni respecto a la técnica quirúrgica a utilizar.

Introduction: Spontaneous pulmonary hernia is a very rare entity. It corresponds to the protrusion of the lung parenchyma and pleura through a chest wall defect. It is caused by increased intrathoracic pressure associated with wall weakness. Case Report: We present the case of an asthmatic patient diagnosed with spontaneous pulmonary hernia of the chest wall and its surgical resolution. Treatment varies according to the case and there is no consensus regarding conservative vs. surgical management or the surgical technique to be used.

Hemangioendotelioma epitelioide pulmonar: Reporte de un caso / Lung epithelioid hemangioendothelioma: Report of one case

Epithelioid hemangioendothelioma is a multifocal tumor that rarely metastasizes. It is difficult to diagnose, most often it is an incidental finding in young asymptomatic women. The radiologic pattern is heterogeneous. Histologic confirmation of Weibel-Palade bodies or immunohistochemistry based on specific tumor markers such as factor VIII and CD34 are the most important finding to confirm the diagnosis. We report a 21 years old woman Presenting with cough and dyspnea. A chest X ray was suggestive of tuberculosis. Sputum smears were negative for acid fat bacilli and the tuberculin test was negative. A chest CAT scan showed multiple nodular lesions. A surgical biopsy of the lesions confirmed the presence of a hemangioendothelioma. The patient was initially treated with prednisone and azathioprine without response. Thereafter, the patient is without treatment and without evidence of disease progression.

Uso de proteína C activada recombinante (Drotrecogin alfa) en sepsis grave de paciente con cirugía cardiaca valvular reciente: reporte de un caso clínico / Use of recombinant active protein C (drotrecogin alfa) in severe sepsis of patient that has recently undergone cardiac valve surgery: report of a clinical case

La sepsis grave en pacientes quirúrgicos tiene una mortalidad elevada. Hay evidencias que el uso de proteína C activada recombinante (Drotrecogin alfa) mejora la sobrevida en estos pacientes. Presentamos el caso de un hombre de 40 años con síndrome de Marfán sometido a cirugía cardiaca valvular que desarrolla sepsis grave por lo cual se administra proteína C activada recombinante con resultados favorables.

Severe sepsis in surgical patients has a high mortality. There is evidence that the use of recombinant human activated protein C (Drotrecogin alfa) improves survival in these patients. We report the use of drotrecogin alfa, in a 40-year-old male with Marfan’s syndrome undergone cardiac valve surgery that develops severe sepsis, with good results.